Advertisement
Canada markets closed
  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CAD/USD

    0.7296
    -0.0024 (-0.33%)
     
  • CRUDE OIL

    82.81
    0.00 (0.00%)
     
  • Bitcoin CAD

    88,112.04
    -2,917.29 (-3.20%)
     
  • CMC Crypto 200

    1,385.35
    -38.75 (-2.72%)
     
  • GOLD FUTURES

    2,329.40
    -9.00 (-0.38%)
     
  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     
  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     
  • NASDAQ futures

    17,467.50
    -197.00 (-1.12%)
     
  • VOLATILITY

    15.97
    +0.28 (+1.78%)
     
  • FTSE

    8,040.38
    -4.43 (-0.06%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • CAD/EUR

    0.6819
    -0.0017 (-0.25%)
     

A Look at Rite Aid’s Fiscal 2019 Guidance

A Look at Rite Aid’s Fiscal 2019 Guidance

Rite Aid’s (RAD) management provided guidance for fiscal 2019 in its fiscal 4Q18 report. Management believes the company will benefit from generic drug purchasing efficiencies, a more stable reimbursement rate environment, Walgreens’s deal-related TSA (Transportation Security Administration) fees, and the company’s ongoing initiatives in fiscal 2019.